News

Filter

Current filters:

Global

201 to 210 of 97199 results

Russia faces steady growth of drug prices

Russia faces steady growth of drug prices

02-12-2014

Drug prices in Russia are steadily growing, due to the deterioration of the local business environment…

PharmaceuticalPharmaceuticals policyPharmacologyPricingRussia

UK Prime Minister to announce £15 million dementia research fund in Autumn Statement

UK Prime Minister to announce £15 million dementia research fund in Autumn Statement

02-12-2014

The UK prime minister David Cameron is to announce a £15 million ($24 million) commitment to a new fund…

NeurologicalPharmaceuticalPoliticsResearchUK

Eli Lilly and AstraZeneca enrol first patient in Phase II/III Alzheimer's therapy trial

Eli Lilly and AstraZeneca enrol first patient in Phase II/III Alzheimer's therapy trial

02-12-2014

US drug major Eli Lilly and AstraZeneca have enrolled the first patient into AMARANTH, a Phase II/III…

AstraZenecaAZD3293Eli LillyNeurologicalPharmaceuticalResearch

FDA accepts NDA filing from AstraZeneca for Iressa

FDA accepts NDA filing from AstraZeneca for Iressa

02-12-2014

The US Food and Drug Administration has accepted for filing the New Drug Application from Iressa (gefitinib)…

AstraZenecaIressaOncologyPharmaceuticalRegulationUK

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

02-12-2014

French drug major Sanofi and North Carolina-based pharma company Pozen have agreed to end their collaboration…

FranceGastro-intestinalsLicensingPA8140/PA32540PharmaceuticalPozenSanofiUSA

Exelixis’ cabozantinib fails to meet primary endpoint in Phase III prostate cancer trial

Exelixis’ cabozantinib fails to meet primary endpoint in Phase III prostate cancer trial

02-12-2014

US biotech firm Exelixis has announced top-line results from the final analysis of COMET-2, a randomized,…

cabozantinibExelixisOncologyPharmaceuticalResearchUSA

Otsuka acquires Avanir for $3.5 billion

Otsuka acquires Avanir for $3.5 billion

02-12-2014

The US subsidiary of Japanese drug maker Otsuka has acquired US CNS specialist Avanir Pharmaceuticals…

AvanirJapanMergers & AcquisitionsNeurologicalNuedextaOtsuka PharmaceuticalPharmaceuticalUSA

NICE reverses October decision and approves Roche's Gazyvaro

NICE reverses October decision and approves Roche's Gazyvaro

02-12-2014

The UK’s National Institute for Health and Care Excellence (NICE) has reversed its decision on Gazyvaro…

GazyvaroOncologyPharmaceuticalRegulationRocheUK

Medical Research Council develops XNAzyme, a world-first synthetic enzyme

Medical Research Council develops XNAzyme, a world-first synthetic enzyme

01-12-2014

Scientists from the UK's Medical Research Council have created the world’s first artificial enzymes…

BiotechnologyChemistryGeneticsMedical Research CouncilResearchUK

201 to 210 of 97199 results

Back to top